Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (14618)	9/16/2000 7:04:34 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Here is why kids with Meninigococcema deserve NEUPREX NOW!!!!!!!!!!! From news article on Phase III results>>>>>>>>>But Giroir noted that the drug, which he said is ``totally safe,'' provided other substantial benefits. Due to the gangrene caused by septic shock, children with the condition sometimes must have full or partial amputation of one or more of their limbs. ``We were able to reduce the number of severe amputations by about 70%,'' Giroir said.<<<<<<<<<<<<<<